The US Food and Drug Administration has given a tentative approval for Aurobindo Pharma to market the generic Famciclovir tablets which are used to treat herpes virus infections. Several studies in humans and mice provide evidence that early treatment with Famciclovir soon after the first infection with herpes can significantly lower the chance of future outbreaks of herpes. Use of Famciclovir in this manner, known as post-exposure prophylaxis, has been shown to reduce the amount of latent virus in the neural ganglia. According to the statement by the company, the FDA has given its approval for the manufacture of the drug in three variants, 125 mg, 250 mg and 500 mg.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Corporate Updates


whatsapp--v1